The National Institute for Health and Care Excellence

MHRA-NICE pathway opens for business – everything you need to know to get started

We use tools such as Google Analytics, Hotjar, Google Optimize and Loop11 to help us anonymously measure how you use our ...
The National Institute for Health and Care Excellence

Injection for more than a million people to help prevent heart attacks and strokes recommended

People who have had a heart attack, stroke, or serious circulation problem in their legs, and who also carry excess weight, can now be offered a weekly injection to help protect them from a further ...
National Institute for Health and Care Excellence

Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity [ID6441]

Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity [ID6441] ...
The National Institute for Health and Care Excellence

NICE recommends new dedicated fertility treatment pathway for endometriosis

This is a direct result of feedback received during public consultation, recognising for the first time that the condition requires its own tailored approach to fertility care, separate from other ...
The National Institute for Health and Care Excellence

Better data for better decisions

Sophie Cooper, Senior Scientific Adviser, explains the importance of the recently published EQ-5D-5L value set and how it has ...
National Institute for Health and Care Excellence

Quality statement 1: Referral to early intervention in psychosis services

Adults with a first episode of psychosis start treatment in early intervention in psychosis services within 2 weeks of referral. Early intervention in psychosis services can improve clinical outcomes, ...
National Institute for Health and Care Excellence

Published guidance, NICE advice and quality standards

Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...
National Institute for Health and Care Excellence

Published guidance, NICE advice and quality standards

Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over TA1140 17 March 2026 17 March 2026 ...
National Institute for Health and Care Excellence

Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils

There is a commercial access agreement for dupilumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact GB-PatientAccess@sanofi.com ...
National Institute for Health and Care Excellence

Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy Technology appraisal guidance TA673 Published: 17 ...
National Institute for Health and Care Excellence

Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues

We have moved interventional procedures guidance 666 to become HealthTech guidance 535. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment ...
National Institute for Health and Care Excellence

Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults

This guideline covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z‑drugs and antidepressants in primary and secondary care. It does not ...